Companies/PharmaCielo Ltd.

Company profile

PharmaCielo Ltd.

OTC: PCLOF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Toronto, ONReports USD

#800 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

40D

FH 42DQ —GM 29SS 53

v0.1 · 45/100 weight · provisional

↑ Piotroski F, workforce scale · ↓ balance-sheet leverage, 3-yr revenue growth

Methodology →

Revenue TTM

$1.9M

Rev growth YoY (TTM)

-26.5%

Net income (FY)

-$2.8M

Employees

268

Market cap

$9.4M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$1.9M2.6M CAD2025

Net income-$2.8M-4.0M CAD2025

Operating income-$2.8M-3.8M CAD2025

Total assets$6.2M8.6M CAD2025

Liabilities$17.4M23.9M CAD2025

Equity-$11.2M-15.3M CAD2025

Revenue trend

FY2018 – FY2025 · USD

FY18

$593.0k

FY19

$2.0M

FY20

$1.6M

FY21

$4.1M

FY22

$1.1M

FY23

$2.5M

FY24

$1.9M

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

PharmaCielo Ltd. booked $1.9M in FY2025 revenue, contracting 27% year over year — slower than 75% of Healthcare companies we track, at a -153.0% net margin.

Peers · Healthcare

Satellos Bioscience Inc.——Qscreen Ai Inc.——1CM Inc.70B Quoin Pharmaceuticals, Ltd.38D

Key facts

CEOMarc Lustig

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersToronto, ON

ExchangeOTC: PCLOF

Employees268

IPO date2019-01-25

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.